Bioprognos is a spin-off of the Hospital Clínic of Barcelona (Barcelona, Catalonia), that seeks to improve clinical outcomes and quality of life for cancer ―as well as other conditions patients (with cardiovascular, neurological or endocrine disorders)―, by developing innovative, non-invasive, accurate, and cost-effective diagnostics solutions that give patients, doctors and payers the information they need from biomarkers found in a simple blood test (as well as urine and other body fluids).